Therapeutic effects of high-dose vitamin C supplementation in patients with COVID-19: a meta-analysis
Nutrition Reviews · 2024
DOI: 10.1093/nutrit/nuad105 ↗Kurz gefasst
Metaanalyse in der Zeitschrift Nutrition Reviews, 2024. Verfasst von Lei Sun und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Environmental Health, School of Public Health, Zhengzhou University, Environment and Health Innovation Team, Zhengzhou, Henan, China. Hauptthemen laut MEDLINE: Ascorbic Acid, COVID-19, COVID-19 Drug Treatment, Dietary Supplements. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 49 Literaturangaben. Gefördert von: National Natural Scientific Foundation of China, Science and Technology Program of Henan Province.
Abstract (Originalsprache)
Context
Coronavirus disease 2019 (COVID-19) could induce the “cytokine storm” due to overactivation of immune system and accompanied by acute respiratory distress syndrome as a serious complication. Vitamin C has been effective in improving lung function of patients by reducing inflammation.
Objective
The aim was to explore the therapeutic effects of high-dose vitamin C supplementation for patients with COVID-19 using meta-analysis. Data Sources Published studies were searched from PubMed, Cochrane Library, Web of Science, EMBASE, and China National Knowledge Infrastructure databases up to August 2022 using the terms “vitamin C” and “COVID-19”. Data analyses were performed independently by 2 researchers using the PRISMA guidelines. Data Extraction Heterogeneity between the included studies was assessed using I2 statistics. When I2 ≥50%, the random-effects model was used; otherwise, a fixed-effects model was applied. Stata 14.0 software was used to pool data by standardized mean differences (SMDs) with 95% CIs or odds ratios (ORs) with 95% CIs. Data Analysis The 14 studies had a total of 751 patients and 1583 control participants in 7 randomized controlled trials and 7 retrospective studies. The vitamin C supplement significantly increased ferritin (SMD = 0.272; 95% CI: 0.059 to 0.485; P = 0.012) and lymphocyte count levels (SMD = 0.376; 95% CI: 0.153 to 0.599; P = 0.001) in patients with COVID-19. Patients administered vitamin C in the length of intensive care unit staying (SMD = 0.226; 95% CI: 0.073 to 0.379; P = 0.004). Intake of vitamin C prominently alleviate disease aggravation (OR = 0.344, 95%CI: 0.135 to 0.873, P = 0.025).
Conclusions
High-dose vitamin C supplementation can alleviate inflammatory response and hinder the aggravation of COVID-19.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Environmental Health, School of Public Health, Zhengzhou University, Environment and Health Innovation Team, Zhengzhou, Henan, China.
- Jinshui District Center for Disease Control and Prevention, Zhengzhou, Henan, China.
Förderung
- National Natural Scientific Foundation of China
- Science and Technology Program of Henan Province
Zitieren
APA
Sun, L., Zhao, J. H., Fan, W. Y., Feng, B., Liu, W. W., Chen, R. Q., Ban, C., Dang, A. G., Wang, M., Luo, K. T., Zhou, G. Y., Yu, F. F., & Ba, Y. (2024). Therapeutic effects of high-dose vitamin C supplementation in patients with COVID-19: a meta-analysis. Nutrition Reviews. https://doi.org/10.1093/nutrit/nuad105
Vancouver
Sun L, Zhao JH, Fan WY, Feng B, Liu WW, Chen RQ, et al. Therapeutic effects of high-dose vitamin C supplementation in patients with COVID-19: a meta-analysis. Nutrition Reviews. 2024. doi:10.1093/nutrit/nuad105
BibTeX
@article{Sun2024,
author = {Sun, Lei and Zhao, Jia-Hao and Fan, Wen-Yi and Feng, Bo and Liu, Wen-Wen and Chen, Rui-Qin and Ban, Chuang and Dang, Ao-Gui and Wang, Miao and Luo, Kang-Ting and Zhou, Guo-Yu and Yu, Fang-Fang and Ba, Yue},
title = {Therapeutic effects of high-dose vitamin C supplementation in patients with COVID-19: a meta-analysis},
journal = {Nutrition Reviews},
year = {2024},
doi = {10.1093/nutrit/nuad105}
}
EUVIMED